These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 15364875

  • 1. Soluble human complement receptor 1 limits ischemic damage in cardiac surgery patients at high risk requiring cardiopulmonary bypass.
    Lazar HL, Bokesch PM, van Lenta F, Fitzgerald C, Emmett C, Marsh HC, Ryan U, OBE and the TP10 Cardiac Surgery Study Group.
    Circulation; 2004 Sep 14; 110(11 Suppl 1):II274-9. PubMed ID: 15364875
    [Abstract] [Full Text] [Related]

  • 2. Beneficial effects of complement inhibition with soluble complement receptor 1 (TP10) during cardiac surgery: is there a gender difference?
    Lazar HL, Keilani T, Fitzgerald CA, Shapira OM, Hunter CT, Shemin RJ, Marsh HC, Ryan US, TP10 Cardiac Surgery Study Group.
    Circulation; 2007 Sep 11; 116(11 Suppl):I83-8. PubMed ID: 17846331
    [Abstract] [Full Text] [Related]

  • 3. The use of TP10, soluble complement receptor 1, in cardiopulmonary bypass.
    Li JS, Jaggers J, Anderson PA.
    Expert Rev Cardiovasc Ther; 2006 Sep 11; 4(5):649-54. PubMed ID: 17081086
    [Abstract] [Full Text] [Related]

  • 4. Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass.
    Shernan SK, Fitch JC, Nussmeier NA, Chen JC, Rollins SA, Mojcik CF, Malloy KJ, Todaro TG, Filloon T, Boyce SW, Gangahar DM, Goldberg M, Saidman LJ, Mangano DT, Pexelizumab Study Investigators.
    Ann Thorac Surg; 2004 Mar 11; 77(3):942-9; discussion 949-50. PubMed ID: 14992903
    [Abstract] [Full Text] [Related]

  • 5. Effect of pexelizumab in coronary artery bypass graft surgery with extended aortic cross-clamp time.
    Smith PK, Carrier M, Chen JC, Haverich A, Levy JH, Menasché P, Shernan SK, Van de Werf F, Adams PX, Todaro TG, Verrier E.
    Ann Thorac Surg; 2006 Sep 11; 82(3):781-8; discussion 788-9. PubMed ID: 16928483
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of complement activation by pexelizumab reduces death in patients undergoing combined aortic valve replacement and coronary artery bypass surgery.
    Carrier M, Ménasché P, Levy JH, Newman MF, Taylor KM, Haverich A, Chen JC, Shernan SK, Van de Werf F, van der Laan M, Todaro TG, Adams PX, Verrier ED.
    J Thorac Cardiovasc Surg; 2006 Feb 11; 131(2):352-6. PubMed ID: 16434264
    [Abstract] [Full Text] [Related]

  • 7. Beneficial effects of C1 esterase inhibitor in ST-elevation myocardial infarction in patients who underwent surgical reperfusion: a randomised double-blind study.
    Fattouch K, Bianco G, Speziale G, Sampognaro R, Lavalle C, Guccione F, Dioguardi P, Ruvolo G.
    Eur J Cardiothorac Surg; 2007 Aug 11; 32(2):326-32. PubMed ID: 17576071
    [Abstract] [Full Text] [Related]

  • 8. A randomized, placebo-controlled trial of complement inhibition in ischemia-reperfusion injury after lung transplantation in human beings.
    Keshavjee S, Davis RD, Zamora MR, de Perrot M, Patterson GA.
    J Thorac Cardiovasc Surg; 2005 Feb 11; 129(2):423-8. PubMed ID: 15678055
    [Abstract] [Full Text] [Related]

  • 9. Pexelizumab reduces death and myocardial infarction in higher risk cardiac surgical patients.
    Haverich A, Shernan SK, Levy JH, Chen JC, Carrier M, Taylor KM, Van de Werf F, Newman MF, Adams PX, Todaro TG, van der Laan M, Verrier ED.
    Ann Thorac Surg; 2006 Aug 11; 82(2):486-92. PubMed ID: 16863750
    [Abstract] [Full Text] [Related]

  • 10. A phase II multicenter double-blind placebo-controlled study of ethyl pyruvate in high-risk patients undergoing cardiac surgery with cardiopulmonary bypass.
    Bennett-Guerrero E, Swaminathan M, Grigore AM, Roach GW, Aberle LG, Johnston JM, Fink MP.
    J Cardiothorac Vasc Anesth; 2009 Jun 11; 23(3):324-9. PubMed ID: 18835526
    [Abstract] [Full Text] [Related]

  • 11. Effects of pyridoxal-5'-phosphate (MC-1) in patients undergoing high-risk coronary artery bypass surgery: results of the MEND-CABG randomized study.
    Tardif JC, Carrier M, Kandzari DE, Emery R, Cote R, Heinonen T, Zettler M, Hasselblad V, Guertin MC, Harrington RA, MEND-CABG Investigators.
    J Thorac Cardiovasc Surg; 2007 Jun 11; 133(6):1604-11. PubMed ID: 17532963
    [Abstract] [Full Text] [Related]

  • 12. EuroSCORE directed intraaortic balloon pump placement in high-risk patients undergoing cardiac surgery--retrospective analysis of 267 patients.
    Diez C, Silber RE, Wächner M, Stiller M, Hofmann HS.
    Interact Cardiovasc Thorac Surg; 2008 May 11; 7(3):389-95. PubMed ID: 18256116
    [Abstract] [Full Text] [Related]

  • 13. Effects of shed mediastinal blood on cardiovascular and pulmonary function: a randomized, double-blind study.
    Boodhwani M, Nathan HJ, Mesana TG, Rubens FD, Cardiotomy Investigators.
    Ann Thorac Surg; 2008 Oct 11; 86(4):1167-73. PubMed ID: 18805154
    [Abstract] [Full Text] [Related]

  • 14. Pharmacologic C5-complement suppression reduces blood loss during on-pump cardiac surgery.
    Chen JC, Rollins SA, Shernan SK, Boyce S, Allen K, Wallace A, Malloy KJ, Eng JS, Colman RW, Fitch JC, Pexelizumab Study Investigators.
    J Card Surg; 2005 Oct 11; 20(1):35-41. PubMed ID: 15673408
    [Abstract] [Full Text] [Related]

  • 15. Long-term amiodarone therapy and the risk of complications after cardiac surgery: results from the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT).
    Crystal E, Kahn S, Roberts R, Thorpe K, Gent M, Cairns JA, Dorian P, Connolly SJ.
    J Thorac Cardiovasc Surg; 2003 Mar 11; 125(3):633-7. PubMed ID: 12658206
    [Abstract] [Full Text] [Related]

  • 16. Administration of C1-esterase inhibitor during emergency coronary artery bypass surgery in acute ST-elevation myocardial infarction.
    Thielmann M, Marggraf G, Neuhäuser M, Forkel J, Herold U, Kamler M, Massoudy P, Jakob H.
    Eur J Cardiothorac Surg; 2006 Aug 11; 30(2):285-93. PubMed ID: 16829095
    [Abstract] [Full Text] [Related]

  • 17. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W, Spannagl M, Boehm J, Hauner K, Braun S, Schuster T, Busley R.
    Anesth Analg; 2008 Nov 11; 107(5):1469-78. PubMed ID: 18931201
    [Abstract] [Full Text] [Related]

  • 18. Intraaortic balloon pumping during cardioplegic arrest preserves lung function in patients with chronic obstructive pulmonary disease.
    Onorati F, Cristodoro L, Bilotta M, Impiombato B, Pezzo F, Mastroroberto P, di Virgilio A, Renzulli A.
    Ann Thorac Surg; 2006 Jul 11; 82(1):35-43. PubMed ID: 16798184
    [Abstract] [Full Text] [Related]

  • 19. Amiodarone prophylaxis for atrial fibrillation of high-risk patients after coronary bypass grafting: a prospective, double-blinded, placebo-controlled, randomized study.
    Budeus M, Hennersdorf M, Perings S, Röhlen S, Schnitzler S, Felix O, Reimert K, Feindt P, Gams E, Lehmann N, Wieneke H, Sack S, Erbel R, Perings C.
    Eur Heart J; 2006 Jul 11; 27(13):1584-91. PubMed ID: 16760210
    [Abstract] [Full Text] [Related]

  • 20. Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery.
    Collard CD, Body SC, Shernan SK, Wang S, Mangano DT, Multicenter Study of Perioperative Ischemia (MCSPI) Research Group, Inc, Ischemia Research and Education Foundation (IREF) Investigators.
    J Thorac Cardiovasc Surg; 2006 Aug 11; 132(2):392-400. PubMed ID: 16872968
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.